Prof Andrea Jorgensen PhD MSc BA ATT ATII

Senior Lecturer, Biostatistics Biostatistics


    Personal Statement

    Andrea Jorgensen is a Senior Lecturer in Biostatistics at the University of Liverpool. She obtained an MSc with distinction in Medical Statistics from Lancaster University in 2004, and a PhD in Medical Statistics from the University of Liverpool in 2010. Andrea leads the Department of Biostatistics' pharmacogenetics research group and is co-lead for the MRC North West Hub for Trials Methodology Research's theme on Efficacy and Mechanisms Evaluation of Targeted Therapies. She also co-leads the MRC Network of Hubs for Trials Methodology Research's Stratified Medicine Working Group. Her research interests are within statistical methods related to pharmacogenetic research, particularly stratified trials, systematic reviews, meta-analysis and analysis of time-to-event data. She also has an interest in statistical methods for personalised/stratified medicine more broadly, including analysis of biomarker data. Andrea works closely with colleagues within the Wolfson Centre for Personalised Medicine and is experienced in analysing large pharmacogenetic datasets across a wide range of therapeutic areas, including anticoagulation, anti-epileptic drugs and asthma.

    Personal Distinctions

    • Systematic Review and Meta-Analysis of Warfarin PGx (Invitation to Speak, North West Pharmacogenomics Research Network Meeting 2009)
    • Epilepsy GWAS (Invitation to Speak, North West Pharmacogenomics Research Network Meeting 2010)
    • Statistics in Pharmacogenetic Studies (Invitation to Speak, Folated Study Group Meeting, University of Wales, Wrexham 2010)
    • The EU-PACT Trial (Invitation to Speak, North and South of England Genetic Epidemiology Groups 2014)
    • The EU-PACT Trial (Invitation to Speak, MRC Network of Hubs for Trials Methodology Research workshop on diagnostics for stratified medicine 2011)
    • Methodological Quality of Pharmacogeentic Studies: Issues of Concern (Invitation to Speak, 56th annual meeting of the German Society for Medical Informatics, Biometry and Epidemiology, Mainz, Germany 2011)
    • Pharmacogenetic studies of benefit & harm with antiepileptic drugs (Invitation to Speak, North West Epilepsy Group 2011)
    • Pharmacogenetics of Warfarin (Invitation to Speak, UK Pharmacogenetics and Stratified Medicine Network 2010)
    • Pharmacogenetics of Warfarin (Invitation to Speak, London Genetics 2010)
    • Pharmacogenetic Studies: Issues of Methodological Quality (Invitation to Speak, Simon Constable 2008)

    Administrative Roles

    • Departmental Health and Safety Co-ordinator
    • Treasurer, Merseyside Local Group of Royal Statistical Society (2011-2015)

    Untitled Document